NO2022047I1 - Formaldehyde inactivated culture of: Salmon Pancreas Disease Virus (SPDV) strain AL V405 - Google Patents

Formaldehyde inactivated culture of: Salmon Pancreas Disease Virus (SPDV) strain AL V405

Info

Publication number
NO2022047I1
NO2022047I1 NO2022047C NO2022047C NO2022047I1 NO 2022047 I1 NO2022047 I1 NO 2022047I1 NO 2022047 C NO2022047 C NO 2022047C NO 2022047 C NO2022047 C NO 2022047C NO 2022047 I1 NO2022047 I1 NO 2022047I1
Authority
NO
Norway
Prior art keywords
spdv
strain
disease virus
pancreas disease
inactivated culture
Prior art date
Application number
NO2022047C
Other languages
Norwegian (no)
Original Assignee
Pharmaq As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51302828&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2022047(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmaq As filed Critical Pharmaq As
Publication of NO2022047I1 publication Critical patent/NO2022047I1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/295Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04Inactivation or attenuation; Producing viral sub-units
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04Inactivation or attenuation; Producing viral sub-units
    • C12N7/06Inactivation or attenuation by chemical treatment
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81Aquaculture, e.g. of fish

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
NO2022047C 2008-02-08 2022-11-15 Formaldehyde inactivated culture of: Salmon Pancreas Disease Virus (SPDV) strain AL V405 NO2022047I1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20080711 2008-02-08

Publications (1)

Publication Number Publication Date
NO2022047I1 true NO2022047I1 (en) 2022-11-15

Family

ID=51302828

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20130833A NO346489B1 (en) 2008-02-08 2013-06-13 Use of inactivated SAV in the manufacture of a vaccine.
NO20191081A NO346254B1 (en) 2008-02-08 2019-09-09 Isolated salmonid alphavirus and its use
NO2022047C NO2022047I1 (en) 2008-02-08 2022-11-15 Formaldehyde inactivated culture of: Salmon Pancreas Disease Virus (SPDV) strain AL V405

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NO20130833A NO346489B1 (en) 2008-02-08 2013-06-13 Use of inactivated SAV in the manufacture of a vaccine.
NO20191081A NO346254B1 (en) 2008-02-08 2019-09-09 Isolated salmonid alphavirus and its use

Country Status (1)

Country Link
NO (3) NO346489B1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0712926B1 (en) * 1994-10-18 2003-10-08 Akzo Nobel N.V. Fish pancreatic disease virus
DK179025B1 (en) * 2005-09-16 2017-08-28 Intervet Int Bv fish vaccine

Also Published As

Publication number Publication date
NO20130833L (en) 2010-07-21
NO346254B1 (en) 2022-05-16
NO346489B1 (en) 2022-09-05
NO20191081A1 (en) 2009-08-10

Similar Documents

Publication Publication Date Title
CY2017004I1 (en) INHIBITORS OF HEPATITIS C VIRUS REPLICATION
CY2015012I2 (en) HEPATITIS C VIRUS INHIBITORS
DK3335728T3 (en) BIOCHEMICALLY STABILIZED HIV-1 ENV TRIMER VACCINE
DK2242752T3 (en) Imidazolyl-biphenylimidazoles as hepatitis C virus inhibitors
BRPI1013393A2 (en) hepatitis c virus inhibitors
BRPI1007836A2 (en) Hepatitis C Virus Inhibitors
DK2245027T3 (en) Hepatitis C virus inhibitors
BRPI0907733A2 (en) Hepatitis C virus inhibitors
BRPI1006141A2 (en) modified antibody compositions, methods for preparing and using them
SMT201400079B (en) Production of poliovirus with high titers for vaccine production
BRPI0919252A2 (en) Methods for cell cultivation, virus propagation and purification
BRPI1012635A2 (en) "methods and compositions for virus immunization"
PL2121011T3 (en) Vaccines including antigen from four strains of influenza virus
DK2358756T4 (en) High affinity human antibodies to PCSK9
BRPI0821252A2 (en) Hepatitis C virus antibodies
ZA201004688B (en) Novel vaccines against multiple subtypes of dengue virus
EA200870304A1 (en) PSEUDOINFECTIONAL FLAVIVIRUS AND ITS APPLICATION
CO6811814A2 (en) Dengue virus vaccine inactivated
DK2019680T3 (en) Increase of titer for vaccination of animals
BRPI0821034A2 (en) Modified Influenza Virus
BRPI0919485A2 (en) vaccines, antigens, plasmodium compositions and methods
DK2307543T3 (en) Improved protein expression system
BRPI1008674A2 (en) Methods of reducing the development of resistant pests.
EP2484378A4 (en) Hepatitis c virus vaccine composition
DK2709656T3 (en) Protein matrix vaccine compositions comprising polycations